Article
SMAD4 mutations causing Myhre syndrome result in disorganization of extracellular matrix improved by losartan.
European journal of human genetics : EJHG - 1 Aug 2014
Piccolo Pasquale, Mithbaokar Pratibha, Sabatino Valeria, Tolmie John, Melis Daniela, Schiaffino Maria Cristina, Filocamo Mirella, Andria Generoso, Brunetti-Pierri Nicola
Abstract excerpt
Myhre syndrome (MS, MIM 139210) is a connective tissue disorder that presents with short stature, short hands and feet, facial dysmorphic features, muscle hypertrophy, thickened skin, and deafness. Recurrent missense mutations in SMAD4 encoding for a transducer mediating transforming growth factor β (TGF-β) signaling are responsible for MS. We found that MS fibroblasts showed increased SMAD4 protein levels,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
